Tosk, a biotech company in San Francisco, is reported to be able to introduce new genetic materials to somatic cells and germ cells in animals by simple injecting genetic materials in the blood stream. Using a combination of transposase and the P-elements from Drosphilia species, the technology is claimed to be able to allow extra DNA to integrate into human and mouse cell culture in high efficiency. It was further indicated that in mice treated with such a technology, as much as 40% of the offsprings carry the transgene.
Full story in the New Scientist, March 27, 2002.
Message posted by: Anthony W.I. Lo
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...